ANIX - Anixa Biosciences Director Acquires 16000 Shares After Exercising Company Stock Options | Benzinga
Lewis H. Titterton Jr., Director at Anixa Biosciences (NASDAQ:ANIX), reported a large exercise of company stock options on October 11, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Jr., Director at Anixa Biosciences, a company in the Health Care sector, just exercised stock options worth 16,000 shares of ANIX stock with an exercise price of $2.58.
Anixa Biosciences shares are trading down 2.82% at $3.21 at the time of this writing on Wednesday morning. Since the current price is $3.21, this makes Jr.'s 16,000 shares worth $51,312.
Now trade stocks online commission free with Charles Schwab, ...